Skip to content

Earnings yield at other companies

PTC Therapeutics logo
PTC TherapeuticsPTCT
15.4%+10.2pp
Edgewise Therapeutics, Inc. logo
Edgewise Therapeutics, Inc.EWTX
-5.2%-1.1pp
Acadia Pharmaceuticals logo
Acadia PharmaceuticalsACAD
9.9%+1.6pp
Dyne Therapeutics, Inc. logo
Dyne Therapeutics, Inc.DYN
-15.1%-5.1pp
Scholar Rock logo
Scholar RockSRRK
-7.2%-1.0pp
Amneal Pharmaceuticals, Inc. logo
Amneal Pharmaceuticals, Inc.AMRX
3.1%+2.7pp

Other financials

Income statement

See full
Revenue$149.4M+5.6%
Gross profit$134.9M+9.2%
Operating income$73.2M+15.6%
Net income$63.7M+12.3%
EPS (diluted)$0.50+11.1%

Balance sheet

See full
Cash & equivalents$755.9M+30.2%
Total debt$2.7M-13.3%
Total equity$1.0B+27.5%
Total assets$1.1B+26.3%

Cash flow

See full
Operating cash flow$59.6M-0.8%
CapEx$27.0K
Free cash flow$59.6M-0.8%

Valuation

See full
Market cap$3.84B+2.7%

Profitability

See full
Gross margin86%-0.2pp
Operating margin44.8%+1.6pp
Net margin37.1%+0.2pp
FCF margin34.9%-15.2pp

Returns & leverage

See full
Return on equity24.5%-4.6pp
Debt / equity0.0×
Current ratio7.1×+1.0×

Where this comes from

Calculated from Catalyst Pharmaceutical’s reported figures.

Based on trailing twelve months.

The official record: Catalyst Pharmaceutical’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Catalyst Pharmaceutical's earnings yield.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Catalyst Pharmaceutical's earnings yield?
Catalyst Pharmaceutical (CPRX) reported earnings yield of 7.3% in Q1 2026.
How has Catalyst Pharmaceutical's earnings yield changed year-over-year?
Catalyst Pharmaceutical's earnings yield increased by 9.2% year-over-year, from 6.7% to 7.3%.
What is the long-term trend for Catalyst Pharmaceutical's earnings yield?
Over 5 years (2020 to 2025), Catalyst Pharmaceutical's earnings yield has grown at a -19.3% compound annual growth rate (CAGR), from 21.8% to 7.5%.
What does earnings yield mean?
Trailing-twelve-month net income divided by market capitalization at the quarter end — the inverse of the P/E ratio, expressed as a percentage.